Arsenic Trioxide Injection shortage

To Be Discontinued 2 presentations · 2 manufacturers · first FDA posting 2026-02-24 · last update 2026-09-21

Manufacturers: Fresenius Kabi USA, LLC, Ingenus Pharmaceuticals LLC

Stated reasons (per FDA): Not stated

Presentations

Presentation	Manufacturer	Status	Reason	Notes (FDA)	Dates
Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 63323-637-10)	Fresenius Kabi USA, LLC	To Be Discontinued	—	Discontinuation of the manufacture of the drug	Posted 09/21/2026 Updated 09/21/2026 Discontinued 09/21/2026
Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 50742-438-10)	Ingenus Pharmaceuticals LLC	To Be Discontinued	—	A business decision was made to discontinue manufacture of the drug.	Posted 02/24/2026 Updated 02/24/2026 Discontinued 02/24/2026